cysteamine has been researched along with Cirrhosis, Liver in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Kohli, R; Lin, CH | 1 |
Barlow, SE; Brunt, EM; Clark, JM; Doo, E; Jain, AK; Karpen, SJ; Kleiner, DE; Kohli, R; Lavine, JE; Molleston, JP; Murray, KF; Neuschwander-Tetri, BA; Rosenthal, P; Schwimmer, JB; Tonascia, J; Van Natta, ML; Vos, MB; Whitington, PF; Wilson, LA; Xanthakos, SA | 1 |
Hathway, DE | 1 |
2 review(s) available for cysteamine and Cirrhosis, Liver
Article | Year |
---|---|
Emerging New Diagnostic Modalities and Therapies of Nonalcoholic Fatty Liver Disease.
Topics: Adolescent; Alanine Transaminase; Antioxidants; Bariatric Surgery; Child; Child, Preschool; Cysteamine; Cystine Depleting Agents; Delayed-Action Preparations; Diet; Humans; Hypoglycemic Agents; Infant; Infant, Newborn; Life Style; Liver Cirrhosis; Metformin; Non-alcoholic Fatty Liver Disease; Pediatric Obesity; Vitamin E | 2020 |
Chemical, biochemical and toxicological differences between carbon tetrachloride and chloroform. A critical review of recent investigations of these compounds in mammals.
Topics: Animals; Biotransformation; Carbon Dioxide; Carbon Tetrachloride; Carcinoma, Hepatocellular; Chemical Phenomena; Chemistry; Chloroform; Cricetinae; Cysteamine; Dogs; Endoplasmic Reticulum; Fatty Liver; Haplorhini; Hydrolysis; Liver Cirrhosis; Liver Neoplasms; Mammals; Mice; Microsomes, Liver; Nephrosis; Rabbits; Rats; Structure-Activity Relationship | 1974 |
1 trial(s) available for cysteamine and Cirrhosis, Liver
Article | Year |
---|---|
In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores.
Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Biopsy; Body Weight; Child; Cysteamine; Cystine Depleting Agents; Delayed-Action Preparations; Double-Blind Method; Female; Hepatitis; Humans; Intention to Treat Analysis; Liver; Liver Cirrhosis; Male; Non-alcoholic Fatty Liver Disease; Severity of Illness Index | 2016 |